These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 4479475)

  • 1. [Differential effects of neuroleptic drugs in chronic schizophrenics. A configuration analytical evaluation].
    Eckmann F; Gebert A; Lienert GA
    Arzneimittelforschung; 1974 Aug; 24(8):1135-8. PubMed ID: 4479475
    [No Abstract]   [Full Text] [Related]  

  • 2. An attempt to classify neuroleptic drugs on the basis of short-term clinical comparative studies.
    Rodová A; Náhunek K; Svestka J
    Act Nerv Super (Praha); 1974 Aug; 16(3):169-70. PubMed ID: 4609274
    [No Abstract]   [Full Text] [Related]  

  • 3. [Current evolution of schizophrenia. Apropos of the evolution of 35 young schizophrenics followed for more than 10 years].
    Lambert PA; Midenet M
    Ann Med Psychol (Paris); 1975 Dec; 2(5):873-91. PubMed ID: 1232901
    [No Abstract]   [Full Text] [Related]  

  • 4. Clinical, toxicological and electroencephalographic study with SCH-12,679 in chronic schizophrenics.
    Keskiner A; Itil TM; Han TH; Saletu B; Hsu W
    Curr Ther Res Clin Exp; 1971 Nov; 13(11):714-25. PubMed ID: 5000719
    [No Abstract]   [Full Text] [Related]  

  • 5. [Clinical trial with Sulpiride and placebo in chronic schizophrenics (study of 89 patients using the Harris-Letemendía-Willems scale)].
    Mezquita Blanco J; Cubillo Sánchez J; Aizpiri Díaz J; Zubia Zubia B
    Arch Neurobiol (Madr); 1972; 35(5):453-72. PubMed ID: 4568565
    [No Abstract]   [Full Text] [Related]  

  • 6. A pilot study of GP-45795 in chronic schizophrenics.
    Sugerman AA
    Curr Ther Res Clin Exp; 1971 Aug; 13(8):549-52. PubMed ID: 4999205
    [No Abstract]   [Full Text] [Related]  

  • 7. Placebo and neuroleptic drug response in schizophrenics in correlation with the "16PF" personality profiles.
    Boleloucký Z; Vinar O; Tosovský J
    Act Nerv Super (Praha); 1973 Aug; 15(3):164-5. PubMed ID: 4769128
    [No Abstract]   [Full Text] [Related]  

  • 8. [Drug withdrawal symptoms following cessation of prolonged neuroleptic therapy].
    Krystof J; Zyg J; Mitkiewicz S; Kaczyński J
    Psychiatr Pol; 1971; 5(4):417-23. PubMed ID: 5112317
    [No Abstract]   [Full Text] [Related]  

  • 9. [Depot neuroleptics - practical method of the longtime treatment and methodological problems of clinical trials (author's transl)].
    Woggon B
    Ther Umsch; 1975 Aug; 32(8):501-6. PubMed ID: 1162636
    [No Abstract]   [Full Text] [Related]  

  • 10. [Clinical testing of a new long-term neuroleptic (Fluspirilene) with special reference to the neuroleptic threshold].
    Haase HJ; Frank T; Knaack M; Lehnhardt C; Richter-Peill H
    Nervenarzt; 1968 Jun; 39(6):275-9. PubMed ID: 5712433
    [No Abstract]   [Full Text] [Related]  

  • 11. Clinical evaluation of mazindol in chronic schizophrenics.
    Krumholz WV; White L
    Curr Ther Res Clin Exp; 1970 Sep; 12(9):609-10. PubMed ID: 4989693
    [No Abstract]   [Full Text] [Related]  

  • 12. [Long-term treatment with flupenthixol. Experiences over a 3-year period].
    Rimestad S
    Nord Med; 1967 Nov; 78(46):1514-8. PubMed ID: 6065207
    [No Abstract]   [Full Text] [Related]  

  • 13. [Evaluation of thiothixene in the therapy of chronic schizophrenia].
    Romaszewska K; Piotrowski A
    Psychiatr Pol; 1970; 4(1):69-71. PubMed ID: 5421205
    [No Abstract]   [Full Text] [Related]  

  • 14. Pimozide (orap, R 6238) in residual schizophrenia. A clinical evaluation with long-term double-blind follow-up.
    Denijs EL; Vereecken JL
    Psychiatr Neurol Neurochir; 1973; 76(1):47-59. PubMed ID: 4699105
    [No Abstract]   [Full Text] [Related]  

  • 15. Schizophrenic subtypes defined by response to drugs and placebo.
    Goldberg SC; Mattsson NB
    Dis Nerv Syst; 1968 May; 29(5):Suppl:153-8. PubMed ID: 4876985
    [No Abstract]   [Full Text] [Related]  

  • 16. Evaluation of loxapine succinate in chronic schizophrenia.
    Clark ML; Huber WK; Sullivan J; Wood F; Costiloe JP
    Dis Nerv Syst; 1972 Dec; 33(12):783-91. PubMed ID: 4589978
    [No Abstract]   [Full Text] [Related]  

  • 17. The effect of octoclothepine on sensorimotor coordination of fine movements in chronic schizophrenics.
    Remr J
    Act Nerv Super (Praha); 1972; 14(2):90-1. PubMed ID: 5040177
    [No Abstract]   [Full Text] [Related]  

  • 18. [Opiran, anxiety and psychosis; apropos of the therapeutic trial of a new incisive neuroleptic drug].
    Giudicelli S
    Ann Med Psychol (Paris); 1972 Mar; 1(3):407-13. PubMed ID: 5066197
    [No Abstract]   [Full Text] [Related]  

  • 19. To the problem of temporary and paemanent effect of drug therapy, particularly in chronic schizophrenia.
    Molcan J; Polák L
    Act Nerv Super (Praha); 1975 Sep; 17(3):203. PubMed ID: 1199693
    [No Abstract]   [Full Text] [Related]  

  • 20. Studies of drug-free schizophrenics and controls.
    Narasimhachari N; Avalos J; Fujimori M; Himwich HE
    Biol Psychiatry; 1973 Dec; 5(3):311-8. PubMed ID: 4513564
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.